| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94K | — | — |
| Cost of Revenue | $1.3M | — | -31.7% |
| Gross Profit | $2.1M | — | -58.9% |
| R&D Expense | $501K | — | -17.8% |
| SG&A Expense | $3.0M | — | -8.0% |
| Operating Income | -$1.3M | — | -197.1% |
| Pre-tax Income | -$1.3M | — | -193.3% |
| Income Tax | $54K | — | -47.1% |
| Net Income | -$1.3M | -67.7% | -205.1% |
| EPS (Basic) | -$0.12 | — | -209.1% |
| EPS (Diluted) | -$0.12 | — | -209.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.9M | -4.0% | +1.3% |
| Accounts Receivable | $4.9M | -10.6% | -44.8% |
| Inventory | $14.4M | +10.0% | -4.1% |
| Current Assets | $39.3M | -4.3% | -13.2% |
| Total Assets | $63.2M | -3.0% | -5.5% |
| Current Liabilities | $10.0M | -2.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$580K | — | -983.5% |
| Investing Cash Flow | -$97K | — | +77.4% |
| Financing Cash Flow | -$67K | — | -2.5% |
| +0.2% |
| Total Liabilities | $18.8M | -3.6% | -4.9% |
| Stockholders' Equity | $44.3M | -2.8% | -5.7% |